SEQUENT SCIENTIFIC Financial Statement Analysis
|
||
The Revenues of SEQUENT SCIENTIFIC have increased by 3.76% YoY .
The Earnings Per Share (EPS) of SEQUENT SCIENTIFIC has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SEQUENT SCIENTIFIC Last 5 Annual Financial Results
[BOM: 512529|NSE : SEQUENT]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,413 Cr | ₹1,362 Cr | ₹1,179 Cr | ₹1,039 Cr | ₹848 Cr |
Expenses | ₹1,303 Cr | ₹1,152 Cr | ₹1,009 Cr | ₹914 Cr | ₹765 Cr |
Operating Profit (Excl OI) | ₹109 Cr | ₹210 Cr | ₹170 Cr | ₹125 Cr | ₹83 Cr |
Other Income | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹8.67 Cr | ₹17 Cr |
Interest | ₹16 Cr | ₹24 Cr | ₹36 Cr | ₹33 Cr | ₹33 Cr |
Depreciation | ₹52 Cr | ₹51 Cr | ₹51 Cr | ₹42 Cr | ₹41 Cr |
Profit Before Tax | ₹53 Cr | ₹137 Cr | ₹94 Cr | ₹59 Cr | ₹24 Cr |
Profit After Tax | ₹45 Cr | ₹104 Cr | ₹82 Cr | ₹57 Cr | ₹10 Cr |
Consolidated Net Profit | ₹41 Cr | ₹95 Cr | ₹70 Cr | ₹49 Cr | ₹422 Cr |
Earnings Per Share (Rs) | ₹-4.86 | ₹1.65 | ₹3.84 | ₹2.81 | ₹1.97 |
PAT Margin (%) | -8.39 | 3.10 | 7.67 | 6.81 | 5.37 |
ROE(%) | -18.95 | 6.56 | 15.00 | 12.06 | 8.63 |
ROCE(%) | -9.71 | 7.01 | 16.24 | 12.59 | 9.24 |
Total Debt/Equity(x) | 0.62 | 0.49 | 0.31 | 0.51 | 0.47 |
Key Financials |
||
Market Cap | : | ₹ 2,979.0 Cr |
Revenue (TTM) | : | ₹ 1,375.2 Cr |
Net Profit(TTM) | : | ₹ -123.3 Cr |
EPS (TTM) | : | ₹ -4.9 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
SEQUENT SCIENTIFIC | -0.9% | -21.7% | 48.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SEQUENT SCIENTIFIC Revenues
[BOM: 512529|NSE : SEQUENT]
Y-o-Y | 3.76 % |
5 Yr CAGR | 13.62 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,413 Cr | 3.76 | |
Mar2022 | ₹1,362 Cr | 15.47 | |
Mar2021 | ₹1,179 Cr | 13.46 | |
Mar2020 | ₹1,039 Cr | 22.58 | |
Mar2019 | ₹848 Cr | - |
SEQUENT SCIENTIFIC Operating Profit
[BOM: 512529|NSE : SEQUENT]
Y-o-Y | -47.90 % |
5 Yr CAGR | 7.15 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹109 Cr | -47.90 | |
Mar2022 | ₹210 Cr | 23.26 | |
Mar2021 | ₹170 Cr | 36.33 | |
Mar2020 | ₹125 Cr | 50.57 | |
Mar2019 | ₹83 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -49.81 % |
5 Yr CAGR | -5.70 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 7.74% | -49.81 | |
Mar2022 | 15.42% | 6.79 | |
Mar2021 | 14.44% | 20.13 | |
Mar2020 | 12.02% | 22.78 | |
Mar2019 | 9.79% | - |
SEQUENT SCIENTIFIC Profit After Tax
[BOM: 512529|NSE : SEQUENT]
Y-o-Y | -57.09 % |
5 Yr CAGR | -44.17 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹41 Cr | -57.09 | |
Mar2022 | ₹95 Cr | 36.53 | |
Mar2021 | ₹70 Cr | 43.66 | |
Mar2020 | ₹49 Cr | -88.46 | |
Mar2019 | ₹422 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -8.39 % | Negative | |
Mar2022 | 3.1 % | -59.58 | |
Mar2021 | 7.67 % | 12.63 | |
Mar2020 | 6.81 % | 26.82 | |
Mar2019 | 5.37 % | - |
SEQUENT SCIENTIFIC Earnings Per Share (EPS)
[BOM: 512529|NSE : SEQUENT]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-4.86 | Negative | |
Mar2022 | ₹1.65 | -57.03 | |
Mar2021 | ₹3.84 | 36.65 | |
Mar2020 | ₹2.81 | 42.64 | |
Mar2019 | ₹1.97 | - |
SEQUENT SCIENTIFIC Return on Capital Employed (ROCE)
[BOM: 512529|NSE : SEQUENT]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | -9.71% | Negative | |
Mar2022 | 7.01% | -56.83 | |
Mar2021 | 16.24% | 28.99 | |
Mar2020 | 12.59% | 36.26 | |
Mar2019 | 9.24% | - |
SEQUENT SCIENTIFIC Share Price vs Sensex
Current Share Price | : | ₹119.4 |
Current MarketCap | : | ₹ 2,979.0 Cr |
Updated EOD on | : | Apr 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -0.9% |
-21.7% |
48.1% |
SENSEX | -2.9% |
-0.4% |
20% |
SEQUENT SCIENTIFIC related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
S&P BSE HEALTHCARE | -3.1% | 2.5% | 51.1% |
You may also like the below Video Courses
FAQ about SEQUENT SCIENTIFIC Financials
How the annual revenues of SEQUENT SCIENTIFIC have changed ?
The Revenues of SEQUENT SCIENTIFIC have increased by 3.76% YoY .
How the Earnings per Share (EPS) of SEQUENT SCIENTIFIC have changed?
The Earnings Per Share (EPS) of SEQUENT SCIENTIFIC has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs